SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-011570
Filing Date
2022-06-13
Accepted
2022-06-13 16:58:09
Documents
13
Period of Report
2022-06-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crsp-20220609.htm   iXBRL 8-K 346672
2 EX-3.1 crsp-ex3_1.htm EX-3.1 510111
  Complete submission text file 0000950170-22-011570.txt   1051399

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crsp-20220609.xsd EX-101.SCH 2464
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crsp-20220609_pre.xml EX-101.PRE 10910
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crsp-20220609_lab.xml EX-101.LAB 13473
7 EXTRACTED XBRL INSTANCE DOCUMENT crsp-20220609_htm.xml XML 4681
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37923 | Film No.: 221012332
SIC: 2836 Biological Products, (No Diagnostic Substances)